šŸ“£ VC round data is live. Check it out!

Cube Labs Valuation Multiples

Discover Cube Labs' revenue and EBITDA valuation multiples and investment history, alongside public comparables like Smart Capital, Banco Actinver, Shareholder Value, FairPlay Properties REIT and more.

Cube Labs Overview

About Cube Labs

Cube Labs SpA operates as a venture builder that enables innovation in the healthcare technology space. The company is engaged in attracting sources of financing and providing entrepreneurial and operational support to the companies to develop healthcare technologies for theĀ market.


Founded

2013

HQ

Italy

Employees

2

Financials (FY)

Revenue: $2M
EBITDA: ($391K)

EV

$63M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Cube Labs Financials

Cube Labs reported last fiscal year revenue of $2M and negative EBITDA of ($391K).

In the same fiscal year, Cube Labs generated $2M in gross profit, ($391K) in EBITDA losses, and had net loss of ($850K).


Cube Labs P&L

In the most recent fiscal year, Cube Labs reported revenue of $2M and EBITDA of ($391K).

Cube Labs is unprofitable as of last fiscal year, with gross margin of 84%, EBITDA margin of (16%), and net margin of (35%).

See analyst estimates for Cube Labs
Last FY20232024202620272028
Revenue$2M$2M$2M
Gross Profit$2M$2M$2M
Gross Margin84%93%84%
EBITDA($391K)($466K)($391K)
EBITDA Margin(16%)(24%)(16%)
EBIT Margin(37%)(39%)(37%)
Net Profit($850K)($808K)($850K)
Net Margin(35%)(42%)(35%)
Net Debt$2M--

Financial data powered by Morningstar, Inc.

Cube Labs Stock Performance

Cube Labs has current market cap of $60M, and enterprise value of $63M.

Market Cap Evolution


Cube Labs' stock price is $2.86.

Cube Labs share price decreased by 0.2% in the last 30 days, and increased by 7.8% in the last year.

Cube Labs has an EPS (earnings per share) of $-0.04.

See more trading valuation data for Cube Labs
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$63M$60M-0.1%-0.2%-7.8%$-0.04

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Cube Labs Valuation Multiples

Cube Labs trades at 25.7x EV/Revenue multiple, and (161.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for Cube Labs

Cube Labs Financial Valuation Multiples

As of June 3, 2026, Cube Labs has market cap of $60M and EV of $63M.

Cube Labs has a P/E ratio of (70.3x).

Last FY20232024202620272028
EV/Revenue25.7x33.1x25.7x
EV/EBITDA(161.4x)(135.3x)(161.4x)
EV/EBIT(69.3x)(84.3x)(69.3x)
EV/Gross Profit30.5x35.6x30.5x
P/E(70.3x)(73.9x)(70.3x)
EV/FCF(19.7x)(13.5x)(19.7x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Cube Labs Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Cube Labs Margins & Growth Rates

In the most recent fiscal year, Cube Labs reported gross margin of 84%, EBITDA margin of (16%), and net margin of (35%).

See estimated margins and future growth rates for Cube Labs

Cube Labs Margins

Last FY2024202720282029
Gross Margin84%84%
EBITDA Margin(16%)(16%)
EBIT Margin(37%)(37%)
Net Margin(35%)(35%)
FCF Margin(130%)(130%)

Cube Labs Growth Rates

23/2426/2727/2828/29
Revenue Growth29%
Gross Profit Growth17%
EBITDA Growth(16%)
EBIT Growth22%
Net Profit Growth5%
FCF Growth(32%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Cube Labs Operational KPIs

Cube Labs' revenue per employee in the last FY averaged $1.2M, while opex per employee averaged $1.5M for the same period.

Access forward-looking KPIs for Cube Labs
Last FY20232024202620272028
Revenue per Employee$1.2M--
Opex per Employee$1.5M--
S&M Expenses to Revenue6%6%6%
G&A Expenses to Revenue45%39%45%
Opex to Revenue121%132%121%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Cube Labs Competitors

Cube Labs competitors include Smart Capital, Banco Actinver, Shareholder Value, FairPlay Properties REIT, Seafire, Hilbert Group, IPOPEMA Securities, Skogsfond Baltikum, Ceiba Investments and Quest for Growth.

Most Cube Labs public comparables operate across Asset Management.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
Smart Capital65.1x-7.3x-
Banco Actinver6.2x-4.4x-
Shareholder Value6.6x---
FairPlay Properties REIT2.0x-4.8x-
Seafire0.8x0.7x9.2x8.0x
Hilbert Group2.9x-(3.1x)-
IPOPEMA Securities0.6x-4.5x-
Skogsfond Baltikum2.7x---

This data is available for Pro users. Sign up to see all Cube Labs competitors and their valuation data.

Start Free Trial

Investments by Cube Labs

Cube Labs has invested in 1 company to date.

Latest investment by Cube Labs was on May 9th 2023. Cube Labs invested in Adamas Biotech in their $100K Strategic investment round (EV/Revenue multiple available to Pro users).

See VC round multiples

Latest Investments by Cube Labs

Adamas Biotech
Description
Adamas Biotech formulates nutraceutical products with green tea extracts exhibiting antioxidant, anti-angiogenic, and anti-inflammatory effects for prostate health and intraepithelial neoplasia prevention. Milan-based, the company supplies clinically validated supplements to wellness brands and healthcare providers in Europe.
HQ CountryItaly
HQ City
Lecce
Deal Date9 May 2023
RoundStrategic investment
Raised$100K
InvestorsCube Labs; Istituto Nazionale Biostrutture e Biosistemi
Valuationundisclosed
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all Cube Labs investments and their VC round multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Cube Labs

When was Cube Labs founded?Cube Labs was founded in 2013.
Where is Cube Labs headquartered?Cube Labs is headquartered in Italy.
How many employees does Cube Labs have?As of today, Cube Labs has over 2 employees.
Is Cube Labs publicly listed?Yes, Cube Labs is a public company listed on Borsa Italiana.
What is the stock symbol of Cube Labs?Cube Labs trades under CUBE ticker.
When did Cube Labs go public?Cube Labs went public in 2023.
Who are competitors of Cube Labs?Cube Labs main competitors include Smart Capital, Banco Actinver, Shareholder Value, FairPlay Properties REIT, Seafire, Hilbert Group, IPOPEMA Securities, Skogsfond Baltikum, Ceiba Investments, Quest for Growth.
What is the current market cap of Cube Labs?Cube Labs' current market cap is $60M.
What is the current revenue of Cube Labs?Cube Labs' last fiscal year revenue is $2M.
What is the current EV/Revenue multiple of Cube Labs?Current revenue multiple of Cube Labs is 25.7x.
Is Cube Labs profitable?No, Cube Labs is not profitable.
How many companies Cube Labs has acquired to date?Cube Labs hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Cube Labs has invested to date?As of June 2026, Cube Labs has invested in 1 company.
What was the last Cube Labs investment?On 9th May 2023 Cube Labs invested in Adamas Biotech, participating in a $100K Strategic investment round, alongside Istituto Nazionale Biostrutture e Biosistemi.
In what companies Cube Labs invested in?Cube Labs invested in Adamas Biotech.

See public comps similar to Cube Labs

Lists including Cube Labs

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial